导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.10% | 635/1050 |
| 近一周 | -1.77% | 644/1104 |
| 近一月 | -6.46% | 911/1103 |
| 近一季 | 17.34% | 50/1092 |
| 近半年 | 3.27% | 364/1070 |
| 近一年 | -17.66% | 865/1018 |
| 近两年 | 62.77% | 419/926 |
| 近三年 | 64.33% | 191/834 |
| 成立以来 | 77.51% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.99% 558/1070 |
-7.96% 865/1101 |
- - |
- - |
| 2025 | 66.83% 73/1065 |
27.21% 5/1014 |
25.98% 6/1038 |
23.27% 501/1050 |
-15.55% 991/1065 |
| 2024 | -7.41% 735/1011 |
-7.78% 688/960 |
-10.32% 874/983 |
27.54% 8/991 |
-12.22% 962/1011 |
| 2023 | 2.35% 72/952 |
-4.61% 784/880 |
-6.11% 581/895 |
9.16% 1/915 |
4.68% 25/952 |
| 2022 | -4.20% 34/867 |
-21.28% 592/773 |
12.64% 172/806 |
-17.70% 696/845 |
31.28% 1/867 |
| 2021 | -5.40% 421/740 |
-6.46% 398/580 |
7.08% 427/659 |
-9.93% 501/704 |
4.85% 235/740 |
| 2020 | 29.57% 350/554 |
-4.23% 265/419 |
17.06% 327/466 |
5.43% 358/517 |
9.62% 370/554 |
| 2019 | - - |
- - |
-3.31% 604/1228 |
-0.37% 342/390 |
6.67% 288/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实互融精选股票A VS. 东吴新产业精选股票A(580008) |